TOT BIOPHARM INTL CO LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 1875 for the last semiannual is 564.14 M HKD, and it's 15.38% higher compared to the previous semiannual. The net income of H1 24 is 34.20 M HKD.